Pronova Defeats Teva, Par In Lovaza Patent Suit

Law360, Los Angeles (May 29, 2012, 10:06 PM EDT) -- A Delaware federal judge ruled Tuesday that Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Inc. infringed two Pronova Biopharma Norge AS patents when they filed applications to sell a generic version of triglyceride-lowering drug Lovaza in 2009.

In a detailed, 50-page decision issued more than a year after a March 2011 bench trial on the infringement claims, U.S. District Judge Sue L. Robinson found that Teva and Par had infringed two of their Norwegian competitor’s patents, ruling that the defendants had failed to prove the patents...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.